Does RISANKIZUMAB-RZAA Cause Thyroid cancer? 43 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Thyroid cancer have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
43
Reports of Thyroid cancer with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
5
Hospitalizations
How Dangerous Is Thyroid cancer From RISANKIZUMAB-RZAA?
Of the 43 reports, 5 (11.6%) required hospitalization.
Is Thyroid cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Thyroid cancer?
RANITIDINE (6,038)
LEVOTHYROXINE (249)
ADALIMUMAB (241)
ETANERCEPT (152)
METHOTREXATE (125)
INTERFERON BETA-1A (101)
INFLIXIMAB (100)
SORAFENIB (100)
EXENATIDE (98)
PAZOPANIB (88)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Thyroid cancer Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA